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Assessment of metabolic 
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urine using 1H NMR spectroscopy
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Alexandros P. Siskos4,5, Elizabeth J. Want4, Toby Athersuch4,6, Remy Slama7, 
Martine Vrijheid1,2,3, Hector C. Keun5 & Muireann Coen4
The application of metabolic phenotyping in clinical and epidemiological studies is limited by a poor 
understanding of inter-individual, intra-individual and temporal variability in metabolic phenotypes. 
Using 1H NMR spectroscopy we characterised short-term variability in urinary metabolites measured 
from 20 children aged 8–9 years old. Daily spot morning, night-time and pooled (50:50 morning and 
night-time) urine samples across six days (18 samples per child) were analysed, and 44 metabolites 
quantified. Intraclass correlation coefficients (ICC) and mixed effect models were applied to assess the 
reproducibility and biological variance of metabolic phenotypes. Excellent analytical reproducibility and 
precision was demonstrated for the 1H NMR spectroscopic platform (median CV 7.2%). Pooled samples 
captured the best inter-individual variability with an ICC of 0.40 (median). Trimethylamine,  
N-acetyl neuraminic acid, 3-hydroxyisobutyrate, 3-hydroxybutyrate/3-aminoisobutyrate, tyrosine, 
valine and 3-hydroxyisovalerate exhibited the highest stability with over 50% of variance specific to 
the child. The pooled sample was shown to capture the most inter-individual variance in the metabolic 
phenotype, which is of importance for molecular epidemiology study design. A substantial proportion 
of the variation in the urinary metabolome of children is specific to the individual, underlining the 
potential of such data to inform clinical and exposome studies conducted early in life.
Metabonomic analysis explores the integrated response of an organism to environmental changes. Increasing 
evidence points toward the critical and long-term involvement of early life environmental exposures and life-
style on later health and disease risk predisposition1. Metabolic profiling is now a well-established top–down 
systems biology approach for characterising the role of metabolism in gene–environment–health interactions2. 
The generalisation of such approaches and systematic prospective collection of blood and urine samples in large 
mother-child cohorts opens up new research opportunities for understanding and discovering the impact of 
pre-natal and post-natal exposures on the onset of child and adult physiological conditions. Numerous metabolic 
phenotyping studies have investigated the impact of anthropometric factors such as age, sex, and obesity in an 
attempt to understand the human metabolome and inter-individual variance3,4. These studies have mainly been 
conducted on adults, whereas studies on children or adolescents are rare. This population requires specific assess-
ment of variance in metabolic phenotypes due to rapid developmental changes, differential lifestyle patterns and 
age-dependent response to environmental factors. Indeed, exposures during the pubertal physiological window 
may be responsible for the later appearance of several metabolic conditions5. In addition, data on short-term 
temporal variability of metabolic phenotypes of repeat urine samples are lacking. One of the major concerns over 
the predictive potential of metabolic phenotyping in the clinic is the temporal variability of the metabolome6,7. 
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A study with access to repeat sampling under controlled conditions with human subjects showed that 22% of 
the identified metabolites in 1H NMR urinary spectroscopic profiles exhibited a significant 24 h cosine rhythm7. 
This effect is believed to be particularly marked in the morning in comparison to the rest of the day. This reflects 
a more pronounced influence on homeostasis when food is consumed after an 8 h fast as compared to a shorter 
inter-meal time interval during the day, which may be due to circadian influences independent of meal consump-
tion6. It has also been shown in in-patient studies with tightly controlled environmental conditions, that diet 
or day-to-day variability do not account for the largest source of variability in either blood or urine metabolic 
profiles8,9.
Even without specific consideration of diurnal effects, studies which have investigated the utility of 
metabonomic approaches in large adult populations showed that 60% (plasma) and 47% (urine) of biologi-
cal variation in 1H NMR-detectable metabolite concentrations was stable and representative of familial and 
individual-environmental factors10. Other recent studies suggest that the stable component of inter-individual 
variation or intraclass correlation (ICC), over a four-month to a year interval was between 0.43 to 0.5710,11. Thus 
the current literature supports the notion that metabolic phenotypes in biofluids are stable over the short to 
medium term in adults, however, equivalent evidence is lacking for children’s biofluids. The unstable component 
of a given metabolic phenotype will complement the study of the stable component, and provides a window into 
the systemic response to acute environmental perturbations, such as dietary change or exposures.
In this study we focus on 1H NMR spectroscopic analyses of urine, which in comparison to blood is a 
non-invasive biofluid to access, making it a more attractive choice for large-scale biological sampling in children. 
We examined the influence of the sample collection time-point of the day on the metabolic phenotype, assessed 
analyte detectability and quantification, and the likely sources of short term variability within and between chil-
dren. We confirm the high analytical reproducibility and robustness of NMR-based urinary metabolic pheno-
typing (as reported elsewhere, ref. 12) and illustrate the benefits of pooling spot urines when seeking the stable 
component of the metabolome.
Results
First morning void and night-time urinary samples were collected from 20 healthy Caucasian children (8–9 years, 
6 females and 14 males), over a period of six days, and pooled 50:50, generating 324 samples in total (36 samples 
were missing randomly across the children and the days, leaving 108 triads with complete morning, night and 
pooled samples for each day). Representative 1H NMR spectra of urine samples obtained from an 8-year old in 
the morning (A), night-time (B), and pooled (C; 50:50 morning and night-time samples) are shown in Fig. 1, 
indicating the coverage of the urinary metabolome in this study.
Analytical variability. As a first step in the characterisation of the stability of child metabolic phenotypes, 
analytical variability of NMR data was assessed to inform on the robustness and stability of the NMR platform. 
Repeat analysis of a representative pooled sample (quality control, QC sample) was conducted. The percentage 
coefficient of variation (CV%) of the QC sample was calculated for integrals of NMR signals representing indi-
vidual metabolites (raw integral divided by the internal reference, before creatinine normalisation) and showed 
an average CV% of 7.2% and median 7.7%. Metabolites with a low signal to noise ratio (S/N) in QCs, such as 
N-methylpicolinic acid, 3-aminoisobutyrate, N1-methylnicotinamide and acetone, presented a CV% over 10%. 
Other metabolites, such as lysine, hippurate, trimethylamine-N-oxide (TMAO), showed the best analytical sta-
bility with a CV% below 3%. The CV% for all identified metabolites (n = 44), are presented in Table 1 along with 
the representative resonance integration windows selected for each metabolite and signal to noise (S/N) ratio.
As a complementary approach to assess analytical and sample processing variability in the biological samples, 
the difference between the daily pool and the average of the morning and the night sample were calculated (named 
%DiffPool, based on 108 paired morning and night samples, raw integral divided by the internal reference). 
The %DiffPool showed an average of 8.7% and a median of 5.4% with more variability captured than the 
CV calculated with the standardised QC samples for certain metabolites such as N-methylpicolinic acid, 
3-aminoisobutyrate, proline betaine, succinate, acetone and carnitine. A detailed table of the metabolite dif-
ferences across morning and night samples per day and per individual also suggests that these six metabolites 
showed the most variability across morning/night samples but with a high intra-day and inter-individual varia-
bility based on visual inspection of the ratios (SI Table 4).
Quantification of urinary metabolites. We quantified urinary metabolites based on peak integrals and 
to account for the short recycle time of the NMR acquisition, and hence incomplete relaxation of 1H nuclei, 
the longitudinal relaxation time, T1, was calculated for each metabolite and a correction factor was applied to 
resulting integrals (SI Table 1). Of the 44 identified metabolites, 18 of them were of low abundance or were only 
detected in a subset of samples, and therefore reliable estimation of their longitudinal relaxation time (T1) was not 
possible (semi-quantification). The final concentration estimates for metabolites (n = 26) are presented in Table 2. 
Creatinine was the most abundant detectable metabolite, with a mean concentration of 5.95 (IQR 4.73–7.24) 
mmol/L, whereas isoleucine was the least abundant metabolite that could be reliably quantified with a mean con-
centration of 2.0 (IQR 1.6–2.3) μ mol/mmol of creatinine in the daily pooled samples. Most metabolites displayed 
a large dynamic range, particularly TMAO, hippurate and creatine with order of magnitude differences between 
minimum and maximum concentration values.
Biological short-term variability in the 1H NMR spectroscopic metabolic profiles of morn-
ing, night-time and pooled urine samples. A key objective of the study was to ascertain whether 
the inter-individual variability captured in the urinary NMR-based metabolic phenotype was greater than the 
intra-individual variability assessed across six days. We simultaneously sought to define which type of urine 
www.nature.com/scientificreports/
3Scientific RepoRts | 7:46082 | DOI: 10.1038/srep46082
sample (morning, night or pool) captured best this inter-individual variability, as this is of relevance in molecular 
epidemiology studies for both study design and biological interpretation. The variability of urinary metabolites 
across six days was assessed independently in morning, night-time and pooled samples based on the intra-class 
correlation coefficient (ICC) (Fig. 2). Metabolites were normalised by creatinine for comparison purposes with 
other studies. We also applied probabilistic quotient normalisation13 to our data, and this showed similar biolog-
ical variability results to the normalisation by creatinine (results not shown). Pooled samples captured the best 
inter-individual variability with 19 out of 44 metabolites with ICC values above 0.5 whereas only 11 and 8 metab-
olites were above ICC 0.5 respectively in morning and night-time samples.
Trimethylamine, N-acetyl neuraminic acid, 3-hydroxyisobutyrate, 3-hydroxybutyrate/3-aminoisobutyrate, 
tyrosine, valine, 3-hydroxyisovalerate were the metabolites that showed the least intra-individual variability with 
ICCs in pooled samples over 0.7, whereas TMAO, proline betaine, acetate, N-methylpicolinic acid were the least 
stable with ICCs under 0.2 (Fig. 2).
Figure 3 clearly shows that TMAO concentration greatly varies over 6 days with overlapping distributions 
across the twenty children. In contrast the precursor of TMAO, trimethylamine, was the most stable metabolite 
measured, with a characteristic concentration range for each child, tightly controlled over six days with limited 
overlap across the children.
The total variance of each metabolite was decomposed according to the longitudinally stable or child 
specific variation (black), diurnal variation (yellow) and residual variation (brown, comprised of techni-
cal variance, between-day variance and unknown) (Fig. 4). The proportion of stable variation representa-
tive of the inter-individual variability showed a large range depending on the metabolite, with an average 
value of 24%. Trimethylamine, short chain fatty acids including 3-hydroxyisovalerate, 3-hydroxyisobutyrate, 
3-hydroxybutyrate/3-aminoisobutyrate, p-hydroxyphenylacetate and some amino acids i.e. tyrosine, lysine and 
valine, exhibited the highest stability with over 50% of variance donor specific. Among the metabolites with a 
residual variance over 80%, are N-methylpicolinic acid, TMAO, dimethylamine, taurine and N-methylnicotinic 
acid which also displayed a high dynamic range in urinary levels. Other metabolites with a high residual variance 
such as succinate, 3-aminoisobutyrate, acetone and acetate also had a high analytical variability in QC samples 
(CVqc). A few metabolites presented a large diurnal variation, in particular N-methylnicotinamide, sucrose, cit-
rate and acetate (20–47% of total variation explained by morning/night sampling).
Further description of the diurnal variation in urinary metabolites show that 15 out 44 metabolites were 
significantly different between morning and night, after accounting for multiple testing (Bonferroni correction; 
Figure 1. A typical 1H NMR spectrum of urine from an 8 year old male child collected in the morning (A), 
night-time (B) and pooled (C; 50:50 morning and night-time) with identified metabolites. Abbreviations: 
2-HB, 2-hydroxybutyrate; 3-HB, 3-hydroxybutyrate; 3-HIV, 3-hydroxyvalerate, 3IS, 3-indoxylsulfate; 4-DEA, 
4-deoxyerythronic acid; 4-DTA, 4-deoxythreonic acid; NAG, N-acetyl glycoprotein fragments; NAN, N-
acetylneuraminic acid; TMAO, trimethylamine-N-oxide.
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p < 0.001). N-methylnicotinamide was particularly increased in morning samples (+ 53% [IQR 25;71%]) com-
pared to the night-time samples (SI Table 2). Sucrose and citrate were lower in morning samples; − 148% [IQR 
− 580;− 15%] and − 52% [IQR − 110; − 14%] respectively, with a large interquartile range across individuals. 
Diurnal changes at the individual and day level are presented in SI Table 4.
Gender differences were also characterised using univariate statistics. After accounting for multiple testing 
(Bonferroni correction; p < 0.001), the concentration of 28 of the 44 measured metabolites were different between 
Metabolite
resonance 
signal (ppm)
integrated region
Signal/Noise 
ratio (log10)
CV (Quality control 
sample, N = 24)
%DiffPool (50:50 
samples, N = 108) ChEBI ID**
lower bound 
(ppm)
upper bound 
(ppm)
2-hydroxyisobutyrate 1.36 (s) 1.362 1.366 3.57 7.3% 3.9% 19641
3-aminoisobutyrate* 2.63 (m) 2.617 2.633 2.94 17.5% 21.5% 49096
3-hydroxybutyrate/3-aminoisobutyrate 1.19 (d) 1.187 1.194 3.45 7.1% 4.9% 37054/49096
3-hydroxyisobutyrate 1.08 (d) 1.078 1.084 3.35 5.6% 4.8% 11805
3-hydroxyisovalerate 1.27 1.272 1.276 3.67 7.5% 4.3% 82957
3-indoxylsulfate 7.52 7.514 7.52 2.95 7.3% 8.5% 43355
4-deoxyerythronic acid 1.1 1.103 1.107 3.24 8.3% 6.3% 86347
4-deoxythreonic acid 1.24 1.239 1.244 3.48 5.5% 4.4% 86391
5-oxoproline 2.39 2.391 2.397 3.23 5.6% 7.2% 16010
Acetate 1.93 1.926 1.93 3.37 10.2% 10.2% 30089
Acetone 2.24 2.238 2.241 2.67 15.6% 19.3% 15347
Alanine 1.49 1.489 1.497 3.91 4.1% 2.2% 16977
Carnitine 3.23 3.227 3.235 4.13 12.1% 18.7% 17126
Citrate 2.54 2.514 2.575 4.91 6.6% 5.5% 30769
Creatine 3.94 3.934 3.94 5.05 4.5% 2.7% 16919
Creatinine 4.06 4.05 4.072 5.44 5.7% 3.1% 16737
Dimethylamine 2.73 2.72 2.736 4.51 4.2% 2.8% 17170
Formate 8.47 8.463 8.467 3.53 8.4% 5.2% 15740
Glucose* 5.25 5.24 5.261 3.72 2.8% 2.7% 17234
Glutamine 2.46 2.435 2.475 4.39 12.6% 11.0% 28300
Glycine 3.57 3.572 3.576 4.46 7.4% 3.8% 15428
Hippurate 7.56 7.538 7.574 4.47 2.4% 3.3% 132966
Isoleucine 1.02 1.018 1.023 2.42 9.4% 10.9% 24898
Lactate 1.33 1.329 1.336 3.75 5.9% 3.8% 24996
Leucine 0.97 0.963 0.969 2.96 6.4% 4.6% 25017
Lysine 1.74 1.715 1.756 3.80 2.3% 4.5% 25094
N1-methylnicotinamide 9.28 9.265 9.292 2.83 12.7% 10.7% 16797
N-acetylneuraminic acid* 2.06 2.054 2.071 4.01 4.4% 3.9% 45744
N-methyl-2-pyridone-5-carboxamide 6.67 6.66 6.681 3.13 9.2% 15.4% 27410
N-methylnicotinic acid 9.12 9.11 9.135 3.07 9.0% 7.3% 50521
N-methylpicolinic acid 8.71 8.698 8.725 1.70 22.0% 60.3% 69061
Pantothenic acid 0.94 0.933 0.938 3.07 6.0% 3.7% 7916
p-cresol sulfate 2.35 2.343 2.349 4.11 5.7% 4.2% 82914
p-hydroxyphenylacetate 6.87 6.871 6.878 3.23 7.8% 5.7% 18101
Proline betaine 3.3 3.301 3.308 3.83 11.0% 20.3% 35280
Scyllo-inositol 3.36 3.362 3.367 3.67 10.8% 9.4% 10642
Succinate 2.41 2.41 2.414 3.85 11.5% 19.6% 26806
Sucrose 5.42 5.41 5.425 3.18 3.7% 8.5% 17992
Taurine 3.43 3.419 3.45 4.67 3.2% 5.9% 15891
Trimethylamine 2.87 2.868 2.872 3.59 8.3% 7.3% 18139
Trimethylamine-N-oxide 3.28 3.265 3.285 5.00 2.5% 7.9% 15724
Tyrosine 6.91 6.905 6.912 3.20 8.2% 5.3% 18186
Urea 5.81 5.675 5.95 5.96 4.1% 2.7% 16199
Valine 1.04 1.039 1.044 2.93 6.7% 4.5% 27266
Table 1.  Analytical variability in urinary metabolites measured in 1H NMR spectra in 24 repeat urine 
samples (pooled representative QC sample) and in 50:50 pool samples. *Multiple overlapping resonances. 
Integral assigned to the most likely, abundant metabolite. **Chemical Entities of Biological Interest (ChEBI), 
dictionary of molecular entities available online at http://www.ebi.ac.uk/chebi/. For metabolites with chiral 
enantiomers, the ID without L or D specification was selected since both forms may be present in human urine.
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females (n = 6) and males (n = 14). Specifically, metabolic phenotypes of males showed the presence of signifi-
cantly higher concentrations of tyrosine, formate and lysine (respectively + 38%, + 40%, + 43%) and lower creati-
nine and deoxythreonic acid compared to females (see SI Table 3 for full non-parametric Mann–Whitney U-test 
results).
Discussion
Our study characterises for the first time short-term temporal variability of the urinary metabolome in children. 
A detailed understanding of such short-term temporal variability and behaviours that influence metabolic phe-
notypes at the individual level enhances their utility in a variety of clinical, epidemiological and occupational con-
texts. We characterised the longitudinal variation in urinary metabolite profiles obtained from children (n = 20) 
twice a day for six days, using 1H NMR spectroscopy. It was possible to decompose the metabolic phenotypic 
diversity observed, and determine stable and unstable temporal variation over six days. In addition, we provided 
evidence of diurnal variation of metabolic signatures and proposed analysis of a pooled urine sample in order to 
capture the largest inter-individual variability. These results can inform on measurement uncertainties for use in 
larger cohort analysis and correct exposure/outcome models based on this error.
Excellent analytical reproducibility and precision (median CV%s 7.2% across all metabolites in repeat anal-
ysis of a quality control pooled sample) in our study provides a strong position for subsequent assessment of 
intra- and inter-individual variability of metabolic phenotypes. 1H NMR profiling provided a broad metabolic 
coverage with phenotypes exhibiting high stability for 18 metabolites (ICC > 0.5) that included trimethylamine, 
N-acetyl neuraminic acid, 3-hydroxyisobutyrate, 3-hydroxybutyrate/3-aminoisobutyrate, tyrosine, valine, 
3-hydroxyisovalerate. Ideally for a metabolite to be validated as a clinical or exposure biomarker, the analytical 
variability and the intra-individual variability must be smaller than the inter-individual variability. The effect 
size for diagnostic purposes should be nested in the inter-individual variability and the residual variability due 
to between day and analytical variability must be smaller than the smallest significant change in metabolite levels 
associated with the phenotype or outcome of interest.
Using mixed effect model analysis-of-variance techniques we quantified the stable proportion of 
between-person variability across six days together with diurnal variation. Our results strongly corroborate ear-
lier findings14–18 including Nicholson et al. which simultaneously estimated familial, individual-environmental, 
short-term dynamic (visit), and non-biological variation in an adult twin study design10. In that study, trimethyl-
amine showed the strongest familial component whereas hippurate exhibited the strongest stable environmental 
Metabolite concentration 
(μmol/mmol creatinine)
Daily Pool 
(n = 108) Morning (n = 108) Night (n = 108)
Creatinine (mmol/L) 6.01 (4.6–7.29) 6.12 (4.12–8.06) 5.24 (3.94–7.21)
2-hydroxyisobutyrate 6.4 (5.8–7.6) 6.8 (5.8–8.2) 6.8 (5.7–7.7)
3-hydroxyisobutyrate 16.4 (12.5–21) 15.1 (11.6–20) 18.7 (13.2–23.8)
4-deoxyerythronic acid 12.5 (10–16.6) 13.6 (10.8–19) 13 (9.6–16.4)
4-deoxythreonic acid 21.3 (17.6–26.3) 24.3 (18.8–27.8) 18.7 (14.1–23.2)
Acetate 9.1 (7.7–11.3) 8.4 (6.5–10.1) 11.4 (8.3–14.6)
Alanine 58.9 (44.9–76.1) 56 (42–67.9) 65.7 (47–87.3)
Carnitine 16.2 (8.9–24.7) 14.6 (7.3–22.2) 20.6 (11.2–31)
Citrate 449.9 (332.4–567.1) 370.3 (262.2–492) 561.4 (352.6–698.8)
Creatine 422.5 (260.8–616) 358.5 (200.4–568.4) 454.7 (306.4–663.6)
Dimethylamine 63.4 (57–76.9) 65 (57.8–74.7) 62.9 (54.5–75.7)
Formate 19.3 (13.8–26) 17.4 (12–23.8) 22.8 (14.7–30.4)
Glutamine 133.3 (112–157.8) 126.8 (102.1–145.4) 135.6 (109.8–168.5)
Glycine 117.1 (88.6–153.1) 112.4 (75.3–155.9) 125.5 (93–178.7)
Hippurate 174 (111.1–249.9) 173 (112.1–236.8) 155.7 (92.5–242.8)
Isoleucine 2 (1.6–2.3) 1.9 (1.6–2.3) 2.1 (1.6–2.6)
Lactate 38.4 (31.4–47.9) 36.3 (28.6–47.9) 39.5 (30.6–57.8)
Leucine 3.3 (2.8–3.7) 3.2 (2.8–3.8) 3.3 (2.6–4.2)
Lysine 39.4 (26.7–55) 41.1 (25–60.7) 38.6 (25.8–53.8)
p-cresol sulfate 47.1 (33.2–63.6) 48.1 (30.8–68.2) 47.4 (31.9–65)
Scyllo-inositol 12.4 (8.4–15.2) 10.7 (7.3–14.3) 12 (8.1–17.2)
Succinate 19.8 (13.4–27.8) 18.6 (9.1–25.4) 26.2 (15.5–35)
Taurine 234.6 (195.3–329.1) 209.6 (139.7–297.4) 284.6 (222.4–364.5)
Trimethylamine 4.4 (3.2–6.4) 4.9 (3.4–6.4) 4.8 (3.3–6.4)
Trimethylamine-N-oxide 111.6 (80.5–216.5) 94.3 (64.9–159.8) 110.3 (80.9–210.7)
Valine 6.5 (4.9–7.4) 6.4 (5.1–7.6) 6.7 (5.1–8.4)
Table 2.  Metabolite concentrations in urine of children aged 8–9 years old sampled daily over 6 days 
measured by 1H NMR spectroscopy. To correct for variations in urine concentration, values for all metabolites 
were normalised to creatinine. Median (interquartile range) are presented.
www.nature.com/scientificreports/
6Scientific RepoRts | 7:46082 | DOI: 10.1038/srep46082
component; both observations confirming a high stability over time. Low inter-individual variability (under 10%) 
for N-methylnicotinic acid and TMAO in our study can easily be explained by dietary influences. Urinary TMAO 
levels are highly related to consumption of foods that contain TMAO (fish) or its dietary precursors, choline, 
betaine and carnitine (eggs and beef) and to gut microbial activity19,20. The high variability observed for urinary 
N-methylnicotinic acid may also result from differing patterns of food intake in children, particularly related to 
coffee or potentially soda drinks and chocolate intake21,22. Other metabolites we identified as highly stable within 
individuals such as p-hydroxyphenylacetate, 3-hydroxyisovalerate, 3-hydroxybutyrate/3-aminoisobutyrate were 
not reported in previous longitudinal variation studies because of limited assignment and possibly because of 
population demographic differences - for example the Nicholson et al. study only investigated post-menopausal 
females. Stable markers such as 3-hydroxyisovalerate and N-acetyl neuraminic acid (also called sialic acid, puta-
tively annotated in our data based on the N-acetyl signal) should be considered in clinical settings since there is 
evidence they may serve as markers of immune-mediated inflammatory diseases (IMIDs), a group of complex 
and prevalent diseases where prognostic monitoring is highly challenging23,24. However, metabolites with high 
Figure 2. Short term variability over six days for 44 metabolites in morning, night-time and pooled 
urine samples based on intra-class correlation coefficients (ICCs) measured in 20 children by 1H NMR 
spectroscopy. Each child was sampled twice daily over a period of one week (morning and night-time).
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variance across six days such as taurine, N-methylpicolinic acid, or during the day such as sucrose, possibly fol-
lowing dietary intake, could be of interest for nutritional epidemiology studies.
Results on sex differences such as increased creatinine excretion in females are different to previous findings in 
adults where creatinine usually correlates with muscle mass25. However, this result, as well as higher citrate excre-
tion in females, corroborates a previous study on sex differences in children of 12–15 years old26 and adults27. 
These results should be corroborated in a larger study.
Future epidemiological studies may choose to analyse morning/night pooled samples in order to capture the 
best inter-individual variability over intra-individual variability. ICCs for pooled samples in our study suggest 
a higher reliability of the urinary metabolite excretion data compared to previous NMR-based metabonomic 
studies where ICCs of 30–37% were found on average for metabolites present across two 24-hour urine col-
lections3. However, the INTERMAP population was substantially larger (n > 2300) and more geographically 
diverse (inter-continental). Our findings are closer to those reported by Floegel and colleagues who found that 
the median ICC over a 4-month interval for 163 sera metabolites measured by mass spectroscopy was 0.5727.
Diurnal variation in urinary excretion affects only a subset of metabolites which are related to known physio-
logical processes and dietary intake. Increased N-methylnicotinamide and creatinine in morning samples com-
pared to night and decreased concentrations of citrate, sucrose, taurine, creatine are in agreement with previous 
studies7,16,18. Interestingly, sucrose which increases in night-time samples in our study, likely due to dietary intake, 
was proposed as a marker of sugar intake in an obese population28. Other metabolites are established to vary 
throughout the day due to physiological processes such as creatinine which fluctuates depending on glomerular 
filtration rate and physical activity29,30. N-methyl nicotinamide in several studies was also shown to be high in the 
morning before breakfast, probably due to reduced enzymatic activity following fasting31.
Overall, the effects of inter-/intra-individual differences on the child urinary metabolome observed in this 
study are very similar to the ones previously observed in adults. Few studies have assessed metabolic variability 
in children/adolescents26,32,33. Strong age effects in the first years of life have been identified in a PCA scores plot 
based on urine 1H NMR spectroscopic profiles from 55 children from newborns to 12 years old31 and related to 
growth spurt during early childhood33. Sex and pubertal development (Tanner stage) were characterised clearly in 
12–15 year old children based on metabolic profiles26. Metabonomics in paediatric populations has mainly found 
applications in respiratory diseases, neuro-developmental and obesity outcomes34–36. However, studies assessing 
the long term stability of the metabolic milieu which represents dietary intake, lifestyle and genetic factors, and 
disease risk factors would be of interest. Using the metabolite profile of healthy children as a phenotyping tool 
has great potential to measure the impact of early environmental exposures. Indeed children are more susceptible 
Figure 3. Distribution of urinary trimethylamine-N-oxide TMAO (top panel) and trimethylamine (bottom 
panel) based on 1H NMR spectra of urine samples obtained from 20 children across morning, night-time 
and pooled samples (50:50 morning and night-time samples). Metabolite integrals were log transformed. 
TMAO, Trimethylamine-N-oxide. A.U. arbitrary units.
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to their environment including factors such as infections, gut microbial variation, pollutants and may undergo 
physiological disturbances which do not display clinical symptoms until adulthood. The HELIX project will use 
information on the child metabolome across six different European countries to characterise the burden and 
effect of environmental exposures37.
Limitations. While the current study design did not directly address long-term stability beyond six days, the 
rate and nature of the changes in metabolic stability is an interesting topic for further research and will be facilitated 
as biobanks grow, providing samples for cohort studies capable of characterizing very long-term molecular variation.
The modest sample size of the sub-cohort characterised in our study (n = 20), did not allow for an analysis 
of further phenotypic variations such as adiposity or relation to environmental exposures. Future work in the 
HELIX study will address this need by allowing comprehensive characterisation of children’s metabolic variability 
in combination with in depth environmental exposure assessment and additional ‘omics analyses (proteomics, 
transcriptomics and epigenomics). Further information on daily dietary intake, physical exercise or physical 
stressors are needed to investigate the relative contribution of lifestyle and circadian rhythm to variance in the 
metabolic phenotype.
Methods
Study population. The Human Early-Life Exposome (HELIX) project aims to integrate novel exposure 
assessment and ‘omics’ technologies to characterise early-life exposure to multiple environmental factors and 
Figure 4. Decomposition of variance for each annotated metabolite resonance in 1H NMR spectra. The 
plot displays estimates for the proportion of biological variance explained by child characteristic (black) and 
diurnal (yellow) components. The remainder of the variance is attributed to day-to-day and technical variability 
and unknown sources (residual, brown). Metabolites are ordered by estimated child specific variance. *Multiple 
overlapping resonances. Integral assigned to the most likely, abundant metabolite.
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associate these with child health outcomes37. HELIX comprises 6 existing birth cohort studies (32,000 moth-
er-child pairs) across Europe, of which 1,200 mother-child pairs were selected for phenotyping including expo-
sure and ‘omics signatures. Smaller nested panel studies (n = 150 children and pregnant mothers) collected 
in-depth personal exposure data and repeat biological samples for a weekly period across two seasons. This study 
focused on a subset of 20 healthy children from the Spanish part of the panel study, nested with the INMA 
(INfancia y Medio Ambiente) cohort in Spain38.
Research has been carried out according to the international and national guidelines and regulations (includ-
ing the declaration of Helsinki). Specifically for Spain, the Spanish Law on Biomedical Research (14/2007, of 3rd 
July). All research protocols were approved by the PS-Mar Ethics Committee (N° 2005/2106/I). Informed consent 
was obtained from all subjects.
Urine sample collection and preparation. Two urine samples per day, first morning void and night-time, 
were collected for six days in 70 ml polypropylene containers. Families recorded the date and time of each collec-
tion prior to storage in a domestic freezer (typically − 20 °C). On day 7, samples were transported from each fam-
ily residence to the analytical laboratory in a − 80 °C freezer, with thawing in transit prevented using cool box ice 
packs. Urines of each child were aliquoted together: urines were defrosted overnight at 4 °C and placed at room 
temperature 30 min before aliquoting. Urines were inverted gently 2–3 times and from each sample three aliquots 
of 1.75 ml in a 2 ml cryovial were made. Aliquots of individual paired daily morning (n = 108) and night-time 
(n = 108) urine collections were pooled (n = 108) to permit a comparison with single morning/night-time uri-
nary collections. The total biological sample size was 344 urines, which included morning, night and daily pooled 
samples. Fifteen samples could not be analysed as a consequence of insufficient sample volume or missed collec-
tion. Aliquots were then stored at − 80 °C until shipment to Imperial College London.
Prior to analysis, samples were thawed and homogenised using a vortex mixer. They were centrifuged at 
13,000 g for 10 min at 4 C to remove insoluble material. 600 μ L of each urine sample was transferred into 96-well 
plates for NMR spectroscopy using a Bruker Sample Track system and a Gilson Liquid Handler 215 preparation 
robot. The robot mixed 540 μ L of sample with 60 μ L of a buffer solution (1.5 M KH2PO4, 2 mM NaN3, 1% 3-(tri-
methylsilyl)-[2,2,3,3-d4]-propionic acid sodium salt (TSP-d4) solution, pH 7.4) and placed it in an NMR tube 
(5 mm Bruker SampleJet NMR tubes).
Quality control (QC) samples were prepared to monitor analytical variability of the metabolic profiling plat-
form. A pooled urine QC sample was prepared by mixing 200 μ l of each individual sample of the study (~60 ml 
total volume). The pooled QC sample was aliquoted into cryovials and stored at − 40 °C for all future analyses. 
A total of 24 QC samples were included in the analytical run, spaced at regular intervals (every 30 samples, four 
newly prepared QC per analytical batch/well plate). To assess stability of one QC sample over time, this was ana-
lysed twice at the beginning and the end of every well plate (4 repeats in total per well plate).
1H NMR spectroscopy analysis. One-dimensional 600 MHz 1H NMR spectra were acquired on a 
BrukerAvance III spectrometer operating at 14.1 Tesla, equipped with a 5 mm broad-band inverse configuration 
probe maintained at 300 K and BrukerSampleJet system with well plates kept at 6 °C. The 1H NMR spectra were 
acquired using a standard one-dimensional solvent suppression pulse sequence (relaxation delay, 90° pulse, 4 μ s 
delay, 90° pulse, mixing time, 90° pulse, acquire FID). For each sample, 128 transients were collected into 64 K data 
points using a spectral width of 12,000 Hz with a recycle delay of 4 s, a mixing time of 100 ms, and an acquisition 
time of 2.73 s. A line-broadening function of 0.3 Hz was applied to all spectra prior to Fourier transformation. All 
1H NMR spectra were automatically phased and baseline-corrected using Topspin 3.2 software (BrukerBioSpin, 
Rheinstetten, Germany). The 1H NMR spectra of urine were referenced to the TSP-d4 resonance at 0 ppm.
Data processing. NMR spectra were imported into the Matlab 2014a (MathWorks, Massachusetts, US) 
computing environment, and were aligned using the recursive segment-wise peak alignment method, an algo-
rithm based on cross-correlation39. The pool QC sample spectrum was used as reference for alignment. A single 
representative resonance in the spectrum was selected for each assigned metabolite, based on presence in a high 
proportion of the spectra, with high signal-to-noise ratio, and exhibiting limited overlap with other resonances. 
Metabolite resonance peak areas were estimated using trapezoidal numerical integration and 44 metabolites were 
obtained using this method. Signal-to-noise ratio to noise ratio (S/N) was calculated with the raw integral for a 
given peak by calculating the root mean square (RMS) noise using a representative noise region of the spectrum 
(9.5–9.9 ppm).
Metabolite quantification using in-house integration routine for a subset of metabolites. The 
concentration of a given metabolite can then be estimated from the signal of the internal standard of known con-
centration, TSP-d4, using the following formula:
= × ×
M
Standard
I
I
N
N
C[ ]
[ ] (1)
m
s
s
m
T1
where [M] is the metabolite molar concentration, [Standard] is the known molar concentration of internal stand-
ard TSP, Im is the metabolite integral, IS is the integral of the TSP-d4 peak, Nm is the number of 1H nuclei contrib-
uting to the metabolite peak, and Ns is the number of 1H nuclei contributing to the internal standard’s peak. CT1 is 
the compensation factor for incomplete longitudinal relaxation. And
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where t, total time per transient, is the sum of recycling delay time and acquisition time of the pulse sequence, 
T1m and T1s are respectively the T1 (longitudinal relaxation time) of the metabolite and the TSP-d4 resonance as 
measured using a standard inversion recovery experiment. For the standard inversion-recovery pulse sequence 
experiment (180° pulse – τ – 90° pulse), variable relaxation delay, τ , was chosen logarithmically to cover values 
from 0.001 to 5 seconds. For each τ, 4 transients were collected into 64 K data points using a spectral width of 
12,000 Hz with a recycle delay of 32 seconds40. T1 values are presented in SI Table 1.
Of the 44 identified metabolites, 18 of them were of low abundance or were only detected in a subset of sam-
ples, and therefore reliable estimation of their longitudinal relaxation time (T1) was not possible.
Metabolites were included in the subsequent data analyses based on quantified values (n = 26) and 
semi-quantified integral values (n = 18) and were normalised to creatinine. Finally, metabolite levels were log–
transformed for the ICC calculation and the decomposition of variance analysis, in order to meet assumptions of 
normality and homoscedasticity in statistical tests and to minimise the influence of extreme values.
Metabolite annotation. Assignment of endogenous urinary metabolites was made by reference to pub-
lished literature data41,42, online databases (HMDB)43, statistical total correlation spectroscopy (STOCSY)44 and 
using ChenomxNMRsuite profiler (ChenomxInc, Edmonton, Canada) and/or confirmed by 2D NMR experi-
ments on a selected sample including homonuclear 1H-1H correlation spectroscopy (COSY), 1H-1H total cor-
relation spectroscopy (TOCSY) and 1H-13C NMR heteronuclear spectroscopy (sample selected based on high 
abundance of doublet at 8.72 ppm). Spike-in experiments using authenticated chemical standards were required 
for certain final metabolite annotations.
Statistical analyses. To determine the reproducibility of the NMR platform we computed the CV (coeffi-
cient of variation, the standard deviation divided by the mean) for a subset of metabolites identified in the QC 
samples which were interspersed across the NMR run. An additional measure of reproducibility was calculated 
for each metabolite based on the % difference between the average of the Morning and Night samples, and the 
Daily Pool (50:50) sample in Sample i, Zi:
≡M Morning urine concentration in Sample ii
≡N Night urine concentration in Sample ii
≡D Daily Pool urine concentration in Sample ii
=
+ −
×Z
M N D
D
( )
100%
(3)
i
i i i
i
1
2
%DiffPool is the median value of {Zi} with n being the number of data pairs (6 days × 20 individuals minus miss-
ing pairs, total n of 108 samples). This represents the typical measurement error in the difference of the pooled 
sample from the average of the morning and night samples.
Intraclass correlation coefficients (ICC) were calculated to investigate the repeatability of metabolites across 
the six day study period independently in pooled, morning and night-time samples. ICC is a measure of the reli-
ability of repeated measures over time, defined as the ratio of between-subject variance to total (between-subject 
plus within-subject). Between and within-subject variance was calculated from the mean squares in the analysis 
of variance using one-way ANOVA fixed effects model using ‘psych’ R package ‘ICC’ function (from CRAN 
repository). We report the ICC for Single_raters_absolute45.
The relative importance attributed to between-individual and diurnal variations were estimated across all 
metabolites based on variance decomposition models. Using linear mixed effect models, by-subject random 
slopes were modelled for within-subject factors. The time of the day (morning/night; diurnal) was added as a 
fixed effect. This regression model was calculated for each metabolite using the R package ‘lme4’ and the function 
lmer46. The proportion of variance explained, or multiple R2, was calculated as ratios of the total variance and rep-
resented as the per cent of variability because of differences between children. In addition, the residual variance 
contains the between day and technical variability but these factors were not added to the model.
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